New bifunctional chelator for 64Cu-immuno-positron emission tomography

Bioconjugate Chemistry

Volumn 24, Issue 8, 2013, Pages 1356-1366

  Pandya, Darpan N ^a   Bhatt, Nikunj ^a   Dale, Ajit V ^a   Kim, Jung Young ^b   Lee, Hochun ^c   Ha, Yeong Su ^a   Lee, Ji Eun ^d   An, Gwang Il ^b   Yoo, Jeongsoo ^a  

^a Kyungpook National University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMS; CARBOXYLATION; COORDINATION REACTIONS; COPPER COMPOUNDS; CYCLIC VOLTAMMETRY; MONOCLONAL ANTIBODIES; PHYSIOLOGICAL MODELS; POSITRON EMISSION TOMOGRAPHY; POSITRONS;

BI-FUNCTIONAL; COPPER ATOMS; CU COMPLEXES; DECOMPLEXATIONS; KINETIC STABILITY; OCTAHEDRAL GEOMETRY; SPECIFIC CONJUGATIONS; SYNTHESISED; TRASTUZUMAB; X-RAY STRUCTURE DETERMINATIONS;

CHELATION;

CARBOXYLIC ACID; CHELATING AGENT; COPPER; COPPER 64; COPPER COMPLEX; CUPRIC ION; FUNCTIONAL GROUP; MACROCYCLIC COMPOUND; NITROGEN; OXYGEN; PENTETIC ACID; TETRAXETAN; TRASTUZUMAB; 1,8-N,N′-BIS-(CARBOXYMETHYL)-4-N″-(4′-ISOTHIOCYANATOPHENETHYL)-1,4,8,11-TETRAAZACYCLOTETRADECANE; ISOTHIOCYANIC ACID DERIVATIVE; MONOCLONAL ANTIBODY; SINGLE HETEROCYCLIC RINGS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOM; CHEMICAL ANALYSIS; CONJUGATION; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DRUG SYNTHESIS; FEMALE; GEOMETRY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ROOM TEMPERATURE; X RAY CRYSTALLOGRAPHY; ANIMAL; BREAST TUMOR; CHEMISTRY; DIAGNOSTIC USE; IMMUNOLOGY; PROCEDURES; SCINTISCANNING; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CHELATING AGENTS; COPPER RADIOISOTOPES; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; ISOTHIOCYANATES; MICE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84883192247     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400192a     Document Type: Article

References (49)

1. Steiner, M. and Neri, D. (2011) Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends Clin. Cancer Res. 17, 6406-6416
2. Wu, A. M. (2009) Antibodies and antimatter: the resurgence of immuno-PET J. Nucl. Med. 50, 2-5
3. Kaur, S., Venktaraman, G., Jain, M., Senapati, S., Garg, P. K., and Batra, S. K. (2012) Recent trends in antibody-based oncologic imaging Cancer Lett. 315, 97-111
4. Chamarthy, M. R., Williams, S. C., and Moadel, R. M. (2011) Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets' Yale J. Biol. Med. 84, 391-407
5. Lee, F. T. (2003) Immuno-PET for tumor targeting J. Nucl. Med. 44, 1282-1283
6. 89Zr-labeled compounds for PET imaging guided personalized therapy Drug Discovery Today: Technol. 8, e53-e61
7. Knowles Scott, M. and Wu Anna, M. (2012) Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology J. Clin. Oncol. 30, 3884-3892
8. van Dongen, G. A. M. S., Visser, G. W. M., Lub-de Hooge, M. N., de Vries, E. G., and Perk, L. R. (2007) Immuno-PET: a navigator in monoclonal antibody development and applications Oncologist 12, 1379-1389
9. Shokeen, M. and Anderson, C. J. (2009) Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET) Acc. Chem. Res. 42, 832-841
10. Kume, M., Carey, P. C., Gaehle, G., Madrid, E., Voller, T., Margenau, W., Welch, M. J., and Lapi, S. E. (2012) A semi-automated system for the routine production of copper-64 Appl. Radiat. Isot. 70, 1803-1806
11. 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody Eur. J. Nucl. Med. Mol. Imaging 34, 850-858
12. 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA PloS One 6, e28005
13. Anderson, C. J., Connett, J. M., Schwarz, S. W., Rocque, P. A., Guo, L. W., Philpott, G. W., Zinn, K. R., Meares, C. F., and Welch, M. J. (1992) Copper-64-labeled antibodies for PET imaging J. Nucl. Med. 33, 1685-1691
14. Anderson, C. J. and Ferdani, R. (2009) Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research Cancer Biother. Radiopharm. 24, 379-393
15. Lewis, M. R., Kao, J. Y., Anderson, A. L., Shively, J. E., and Raubitschek, A. (2001) An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA Bioconjugate Chem. 12, 320-324
16. 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT EJNMMI Res. 1, 15
17. 64Cu-BAT-2IT-1A3 Cancer Biother. Radiopharm. 16, 483-494
18. Moi, M. K., Meares, C. F., McCall, M. J., Cole, W. C., and DeNardo, S. J. (1985) Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent Anal. Biochem. 148, 249-253
19. Bass, L. A., Wang, M., Welch, M. J., and Anderson, C. J. (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver Bioconjugate Chem. 11, 527-532
20. Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., and Anderson, C. J. (2004) Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes J. Med. Chem. 47, 1465-1474
21. Sampath, L., Kwon, S., Hall, M. A., Price, R. E., and Sevick-Muraca, E. M. (2010) Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent Transl. Oncol. 3, 307-317
22. 64Cu antibody imaging Eur. J. Nucl. Med. Mol. Imaging 37, 2117-2126
23. Rogers, B. E., Anderson, C. J., Connett, J. M., Guo, L. W., Edwards, W. B., Sherman, E. L., Zinn, K. R., and Welch, M. J. (1996) Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism Bioconjugate Chem. 7, 511-522
24. 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging Nucl. Med. Biol. 30, 417-427
25. 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors J. Nucl. Med. 49, 1819-1827
26. Anderson, C. J., Wadas, T. J., Wong, E. H., and Weisman, G. R. (2008) Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging Q. J. Nucl. Med. Mol. Imaging 52, 185-192
27. 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors Nucl. Med. Biol. 40, 245-251
28. 64Cu labeled Tyr3-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator Bioconjugate Chem. 23, 1470-1477
29. Pandya, D. N., Kim, J. Y., Park, J. C., Lee, H., Phapale, P. B., Kwak, W., Choi, T. H., Cheon, G. J., Yoon, Y.-R., and Yoo, J. (2010) Revival of TE2A; a better chelate for Cu(II) ions than TETA? Chem. Commun. 46, 3517-3519
30. 64Cu Nucl. Med. Mol. Imaging 44, 185-192
31. Sprague, J. E., Peng, Y., Fiamengo, A. L., Woodin, K. S., Southwick, E. A., Weisman, G. R., Wong, E. H., Golen, J. A., Rheingold, A. L., and Anderson, C. J. (2007) Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents J. Med. Chem. 50, 2527-2535
32. Jones-Wilson, T. M., Deal, K. A., Anderson, C. J., McCarthy, D. W., Kovacs, Z., Motekaitis, R. J., Sherry, A. D., Martell, A. E., and Welch, M. J. (1998) The in vivo behavior of copper-64-labeled azamacrocyclic complexes Nucl. Med. Biol. 25, 523-530
33. Yoo, J., Reichert, D. E., and Welch, M. J. (2004) Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution J. Med. Chem. 47, 6625-6637
34. Harris, M. (2004) Monoclonal antibodies as therapeutic agents for cancer Lancet Oncol. 5, 292-302
35. Pegram, M. and Liao, J. (2012) Trastuzumab treatment in multiple lines: current data and future directions Clin. Breast Cancer 12, 10-18
36. Kang, H. S., Huh, Y. M., Kim, S., and Lee, D.-k. (2009) Isolation of RNA aptamers targeting HER-2-overexpressing breast cancer cells using cell-SELEX Bull. Korean Chem. Soc. 30, 1827-1831
37. Lee, J. H., Huh, Y. M., Jun, Y. W., Seo, J. W., Jang, J. T., Song, H. T., Kim, S., Cho, E. J., Yoon, H. G., Suh, J. S., and Cheon, J. (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging Nat. Med. 13, 95-99
38. Yang, J., Lee, C.-H., Ko, H.-J., Suh, J.-S., Yoon, H.-G., Lee, K., Huh, Y.-M., and Haam, S. (2007) Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer Angew. Chem., Int. Ed. 46, 8836-8839
39. 64Cu-radiolabeled bioconjugate Bioconjugate Chem. 23, 330-335
40. 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression Nucl. Med. Biol. 38, 331-337
41. McMurry, T. J., Brechbiel, M., Kumar, K., and Gansow, O. A. (1992) Convenient synthesis of bifunctional tetraaza macrocycles Bioconjugate Chem. 3, 108-117
42. Brechbiel, M. W., Gansow, O. A., Atcher, R. W., Schlom, J., Esteban, J., Simpson, D., and Colcher, D. (1986) Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies Inorg. Chem. 25, 2772-2781
43. McMurry, T. J., Brechbiel, M., Wu, C., and Gansow, O. A. (1993) Synthesis of 2-(p-thiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid: Application of the 4-methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines Bioconjugate Chem. 4, 236-245
44. Woodin, K. S., Heroux, K. J., Boswell, C. A., Wong, E. H., Weisman, G. R., Niu, W., Tomellini, S. A., Anderson, C. J., Zakharov, L. N., and Rheingold, A. L. (2005) Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: possible implications for in vivo stability Eur. J. Inorg. Chem. 2005, 4829-4833
45. Kotek, J., Lubal, P., Hermann, P., Cisarova, I., Lukes, I., Godula, T., Svobodova, I., Taborsky, P., and Havel, J. (2003) High thermodynamic stability and extraordinary kinetic inertness of copper(II) complexes with 1,4,8,11-tetraazacyclotetradecane-1,8-bis(methylphosphonic acid): example of a rare isomerism between kinetically inert penta- and hexacoordinated copper(II) complexes Chem.-Eur. J. 9, 233-248
46. Dong, Y., Lawrance, G. A., Lindoy, L. F., and Turner, P. (2003) Macrocyclic ligand design. Interaction of a series of successively N-benzylated derivatives of 1,4,8,11-tetraazacyclotetradecane (cyclam) with copper(II) and nickel(II) Dalton Trans. 1567-1576
47. Chapman, J., Ferguson, G., Gallagher, J. F., Jennings, M. C., and Parker, D. (1992) Copper and nickel complexes of 1,8-disubstituted derivatives of 1,4,8,11-tetraazacyclotetradecane J. Chem. Soc., Dalton Trans. 345-353
48. Paudyal, P., Paudyal, B., Hanaoka, H., Oriuchi, N., Iida, Y., Yoshioka, H., Tominaga, H., Watanabe, S., Ishioka, N. S., and Endo, K. (2010) Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET Cancer Sci. 101, 1045-1050
49. 64Cu-DOTA-trastuzumab Eur. J. Nucl. Med. Mol. Imaging 36, 1510-1519